Kallikrein Gene Delivery Attenuates Hypertension and Cardiac Hypertrophy and Enhances Renal Function in Goldblatt Hypertensive Rats
- 1 May 1998
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 31 (5) , 1104-1110
- https://doi.org/10.1161/01.hyp.31.5.1104
Abstract
—To demonstrate potential therapeutic effects of kallikrein gene delivery, we delivered adenovirus (Ad.CMV-cHK) carrying the human tissue kallikrein gene into two-kidney, one-clip Goldblatt...Keywords
This publication has 23 references indexed in Scilit:
- Kallikrein gene therapy in newborn and adult hypertensive ratsCanadian Journal of Physiology and Pharmacology, 1997
- Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vectorGene Therapy, 1997
- Systemic and Portal Vein Delivery of Human Kallikrein Gene Reduces Blood Pressure in Hypertensive RatsHuman Gene Therapy, 1996
- High Level of Circulating Human Tissue Kallikrein Induces Hypotension in a Transgenic Mouse ModelClinical and Experimental Hypertension, 1996
- Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.Journal of Clinical Investigation, 1995
- Human tissue kallikrein induces hypotension in transgenic mice.Hypertension, 1994
- Modulation of renin-angiotensin and kallikrein gene expression in experimental hypertension.Hypertension, 1994
- A gene for high urinary kallikrein may protect against hypertension in Utah kindreds.Hypertension, 1989
- Antihypertensive effect of orally administered glandular kallikrein in essential hypertension. Results of double blind study.Hypertension, 1981
- Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseases.Japanese Circulation Journal, 1981